Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
24-26 June, 2025
Europ. Pharma Outsourc...Europ. Pharma Outsourcing
Not Confirmed
Not Confirmed
05-06 June, 2025
Not Confirmed
Not Confirmed
05-06 June, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
24-26 June, 2025
Europ. Pharma Outsourc...Europ. Pharma Outsourcing
Industry Trade Show
Not Confirmed
05-06 June, 2025
Industry Trade Show
Not Confirmed
05-06 June, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/alchem-nicselect-grants-customers-royalty-free-access-to-t-max-tech-for-3-in-1-vape-satisfaction-in-flavour-restricted-markets
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/excipient-market-overview-roquette-announces-restructuring-post-iff-pharma-buyout-who-fda-advance-regulatory-frameworks
12 May 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250512803482/en/Epicrispr-Biotechnologies-Named-Finalist-in-XPRIZE-Healthspan-Competition-FSHD-Bonus-Prize
05 May 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250505956612/en/Epicrispr-Biotechnologies-Announces-Five-Presentations-Highlighting-Advances-in-Epigenetic-Modulation-and-AAV-Manufacturing-at-ASGCT-2025-Annual-Meeting
23 Apr 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250423098005/en/Epicrispr-Biotechnologies-Partners-with-Springbok-Analytics-to-Integrate-AI-Muscle-Analysis-in-First-in-Human-FSHD-Study
03 Apr 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250403888509/en/Epicrispr-Biotechnologies-Announces-FDA-Clearance-of-IND-Application-for-EPI-321-A-First-in-Class-Epigenetic-Therapy-for-FSHD
26 Mar 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250326428705/en/Epicrispr-Biotechnologies-Secures-%2468-Million-Series-B-to-Initiate-Clinical-Trial-for-First-in-Class-Disease-Modifying-Epigenetic-Neuromuscular-Therapy-for-FSHD
22 Oct 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/10/22/2966640/0/en/Epicrispr-Biotechnologies-Presents-Data-on-Powerful-Gene-Reactivation-with-GEMS-Epigenetic-Editors-at-ESGCT.html
ABOUT THIS PAGE